Control-IQ Technology in the Real World: The First 30 Days

This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.

Key messages

• The t:slim X2 insulin pump with Control-IQ technology from Tandem Diabetes Care, Inc. was cleared by the Food and Drug Administration in December 2019. 
• This was a retrospective analysis of users who uploaded at least 30 days of pre and 30 days of post Control-IQ software update usage data
• The Control-IQ software update led to a 10% increase (p<0.001) of median sensor time in range (70-180 mg/dL) to 78% due to a 10% decrease in sensor time >180mg/dL to 21% and a 0.1% decrease of sensor time <70 mg/dL to 1.1%.